Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Increasing Dietary Vitamin K Intake Stabilizes Anticoagulation Therapy in Warfarin-Treated Patients with a History of Instability: A 24-week Randomized Controlled Trial (OR36-04-19).

Ferland G, Chahine S, Presse N, Dube MP, Nigam A, Blostein M, deDenus S, Perreault S, Tardif JC.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz035.OR36-04-19. doi: 10.1093/cdn/nzz035.OR36-04-19. eCollection 2019 Jun.

2.

Blood pressure and burden of hypertension in Cameroon, a microcosm of Africa: a systematic review and meta-analysis of population-based studies.

Kuate Defo B, Mbanya JC, Kingue S, Tardif JC, Choukem SP, Perreault S, Fournier P, Ekundayo O, Potvin L, D'Antono B, Emami E, Cote R, Aubin MJ, Bouchard M, Khairy P, Rey E, Richard L, Zarowsky C, Mampuya WM, Mbanya D, Sauvé S, Ndom P, Silva RBD, Assah F, Roy I, Dubois CA.

J Hypertens. 2019 Jun 3. doi: 10.1097/HJH.0000000000002165. [Epub ahead of print]

PMID:
31166251
3.

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage.

Perreault S, Côté R, White-Guay B, Dorais M, Oussaïd E, Schnitzer ME.

J Stroke. 2019 May;21(2):195-206. doi: 10.5853/jos.2018.02243. Epub 2019 May 31.

4.

Healthcare expenses for treatment of acute myeloid leukemia.

Bewersdorf JP, Shallis RM, Wang R, Huntington SF, Perreault S, Ma X, Zeidan AM.

Expert Rev Hematol. 2019 Jun 13:1-10. doi: 10.1080/17474086.2019.1627869. [Epub ahead of print]

PMID:
31159602
5.

Seizures in Pediatric Patients With Primary Brain Tumors.

Robert-Boire V, Desnous B, Lortie A, Carmant L, Ellezam B, Weil AG, Perreault S.

Pediatr Neurol. 2019 Mar 28. pii: S0887-8994(18)31352-3. doi: 10.1016/j.pediatrneurol.2019.03.020. [Epub ahead of print]

PMID:
31036424
6.

Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.

Khater F, Vairy S, Langlois S, Dumoucel S, Sontag T, St-Onge P, Bittencourt H, Dal Soglio D, Champagne J, Duval M, Leclerc JM, Laverdiere C, Tran TH, Patey N, Ellezam B, Perreault S, Piché N, Samson Y, Teira P, Jabado N, Michon B, Brossard J, Marzouki M, Cellot S, Sinnett D.

JAMA Netw Open. 2019 Apr 5;2(4):e192906. doi: 10.1001/jamanetworkopen.2019.2906.

7.

Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice.

Lahcene H, Aprikian AG, Vanhuyse M, Hu J, Bladou F, Cury F, Kassouf W, Perreault S, Dragomir A.

J Oncol Pharm Pract. 2019 Apr 18:1078155219842329. doi: 10.1177/1078155219842329. [Epub ahead of print]

PMID:
30997868
8.

Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study.

Croteau C, Mottron L, Dorais M, Tarride JE, Perreault S.

Autism. 2019 Apr 4:1362361319840229. doi: 10.1177/1362361319840229. [Epub ahead of print]

PMID:
30943759
9.

A Validation Study of Administrative Health Care Data to Detect Acute Kidney Injury in the Pediatric Intensive Care Unit.

D'Arienzo D, Hessey E, Ali R, Perreault S, Samuel S, Roy L, Lacroix J, Jouvet P, Morissette G, Dorais M, Lafrance JP, Phan V, Pizzi M, Chanchlani R, Zappitelli M.

Can J Kidney Health Dis. 2019 Feb 10;6:2054358119827525. doi: 10.1177/2054358119827525. eCollection 2019.

10.

Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure?

Korol S, White M, O'Meara E, Rouleau JL, White-Guay B, Dorais M, Ahmed A, de Denus S, Perreault S.

Eur J Clin Pharmacol. 2019 Jun;75(6):837-847. doi: 10.1007/s00228-018-02615-8. Epub 2019 Feb 13.

PMID:
30758517
11.

Rationale, study design, and descriptive data of the Lucky Bone™ Fracture Liaison Service.

Senay A, Perreault S, Delisle J, Morin SN, Raynauld JP, Banica A, Troyanov Y, Beaumont P, Jodoin A, Laflamme GY, Leduc S, Mac-Thiong JM, Nguyen H, Ranger P, Rouleau DM, Fernandes JC.

Arch Osteoporos. 2019 Feb 12;14(1):19. doi: 10.1007/s11657-019-0571-8.

PMID:
30756193
12.

The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).

Perreault S, McManus D, Bar N, Foss F, Gowda L, Isufi I, Seropian S, Malinis M, Topal JE.

Transpl Infect Dis. 2019 Apr;21(2):e13059. doi: 10.1111/tid.13059. Epub 2019 Feb 22.

PMID:
30737868
13.

Impact of Psychoactive Drug Use on Developing Obesity among Children and Adolescents with Autism Spectrum Diagnosis: A Nested Case-Control Study.

Croteau C, Ben Amor L, Ilies D, Mottron L, Tarride JE, Dorais M, Perreault S.

Child Obes. 2019 Feb/Mar;15(2):131-141. doi: 10.1089/chi.2018.0170. Epub 2019 Jan 22.

PMID:
30668140
14.

Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.

Khater F, Langlois S, Cassart P, Roy AM, Lajoie M, Healy J, Richer C, St-Onge P, Piché N, Perreault S, Cellot S, Marzouki M, Jabado N, Sinnett D.

Oncogene. 2019 Apr;38(16):2994-3002. doi: 10.1038/s41388-018-0623-3. Epub 2018 Dec 21.

PMID:
30575814
15.

MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.

Iv M, Zhou M, Shpanskaya K, Perreault S, Wang Z, Tranvinh E, Lanzman B, Vajapeyam S, Vitanza NA, Fisher PG, Cho YJ, Laughlin S, Ramaswamy V, Taylor MD, Cheshier SH, Grant GA, Young Poussaint T, Gevaert O, Yeom KW.

AJNR Am J Neuroradiol. 2019 Jan;40(1):154-161. doi: 10.3174/ajnr.A5899. Epub 2018 Dec 6.

PMID:
30523141
16.

Lasso Regression for the Prediction of Intermediate Outcomes Related to Cardiovascular Disease Prevention Using the TRANSIT Quality Indicators.

Khanji C, Lalonde L, Bareil C, Lussier MT, Perreault S, Schnitzer ME.

Med Care. 2019 Jan;57(1):63-72. doi: 10.1097/MLR.0000000000001014.

PMID:
30439793
17.

Correction: Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation.

Koczkowska M, Callens T, Gomes A, Sharp A, Chen Y, Hicks AD, Aylsworth AS, Azizi AA, Basel DG, Bellus G, Bird LM, Blazo MA, Burke LW, Cannon A, Collins F, DeFilippo C, Denayer E, Digilio MC, Dills SK, Dosa L, Greenwood RS, Griffis C, Gupta P, Hachen RK, Hernández-Chico C, Janssens S, Jones KJ, Jordan JT, Kannu P, Korf BR, Lewis AM, Listernick RH, Lonardo F, Mahoney MJ, Ojeda MM, McDonald MT, McDougall C, Mendelsohn N, Miller DT, Mori M, Oostenbrink R, Perreault S, Pierpont ME, Piscopo C, Pond DA, Randolph LM, Rauen KA, Rednam S, Rutledge SL, Saletti V, Schaefer GB, Schorry EK, Scott DA, Shugar A, Siqveland E, Starr LJ, Syed A, Trapane PL, Ullrich NJ, Wakefield EG, Walsh LE, Wangler MF, Zackai E, Claes KBM, Wimmer K, van Minkelen R, De Luca A, Martin Y, Legius E, Messiaen LM.

Genet Med. 2019 Mar;21(3):764-765. doi: 10.1038/s41436-018-0326-8.

PMID:
30275510
18.

Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation.

Koczkowska M, Callens T, Gomes A, Sharp A, Chen Y, Hicks AD, Aylsworth AS, Azizi AA, Basel DG, Bellus G, Bird LM, Blazo MA, Burke LW, Cannon A, Collins F, DeFilippo C, Denayer E, Digilio MC, Dills SK, Dosa L, Greenwood RS, Griffis C, Gupta P, Hachen RK, Hernández-Chico C, Janssens S, Jones KJ, Jordan JT, Kannu P, Korf BR, Lewis AM, Listernick RH, Lonardo F, Mahoney MJ, Ojeda MM, McDonald MT, McDougall C, Mendelsohn N, Miller DT, Mori M, Oostenbrink R, Perreault S, Pierpont ME, Piscopo C, Pond DA, Randolph LM, Rauen KA, Rednam S, Rutledge SL, Saletti V, Schaefer GB, Schorry EK, Scott DA, Shugar A, Siqveland E, Starr LJ, Syed A, Trapane PL, Ullrich NJ, Wakefield EG, Walsh LE, Wangler MF, Zackai E, Claes KBM, Wimmer K, van Minkelen R, De Luca A, Martin Y, Legius E, Messiaen LM.

Genet Med. 2019 Apr;21(4):867-876. doi: 10.1038/s41436-018-0269-0. Epub 2018 Sep 7. Erratum in: Genet Med. 2019 Mar;21(3):764-765.

PMID:
30190611
19.

Trametinib for progressive pediatric low-grade gliomas.

Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L, Sinnett D, Legault G, Crevier L, Weil A, Farmer JP, Jabado N, Perreault S.

J Neurooncol. 2018 Nov;140(2):435-444. doi: 10.1007/s11060-018-2971-9. Epub 2018 Aug 10.

PMID:
30097824
20.

Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation.

Kim TK, DeVeaux M, Stahl M, Perreault S, Isufi I, Cooper D, Foss F, Shlomchik W, Zelterman D, Zeidan AM, Seropian S.

Ann Hematol. 2019 Jan;98(1):237-240. doi: 10.1007/s00277-018-3427-1. Epub 2018 Jul 19. No abstract available.

PMID:
30027436
21.

Atropisomerism by Design: Discovery of a Selective and Stable Phosphoinositide 3-Kinase (PI3K) β Inhibitor.

Chandrasekhar J, Dick R, Van Veldhuizen J, Koditek D, Lepist EI, McGrath ME, Patel L, Phillips G, Sedillo K, Somoza JR, Therrien J, Till NA, Treiberg J, Villaseñor AG, Zherebina Y, Perreault S.

J Med Chem. 2018 Aug 9;61(15):6858-6868. doi: 10.1021/acs.jmedchem.8b00797. Epub 2018 Jul 30.

PMID:
30015489
22.

Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas.

Rosca L, Robert-Boire V, Delisle JF, Samson Y, Perreault S.

Pediatr Blood Cancer. 2018 Nov;65(11):e27351. doi: 10.1002/pbc.27351. Epub 2018 Jul 16.

PMID:
30014595
23.

Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies.

Perreault S, McManus D, Anderson A, Lin T, Ruggero M, Topal JE.

J Oncol Pharm Pract. 2018 Jan 1:1078155218786028. doi: 10.1177/1078155218786028. [Epub ahead of print]

PMID:
29996736
24.

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM.

Leuk Lymphoma. 2019 Jan;60(1):246-249. doi: 10.1080/10428194.2018.1468893. Epub 2018 Jul 2. No abstract available.

PMID:
29963936
25.

Narcolepsy and Hypothalamic Region Tumors: Presentation and Evolution.

Weil AG, Muir K, Hukin J, Desautels A, Martel V, Perreault S.

Pediatr Neurol. 2018 Jul;84:27-31. doi: 10.1016/j.pediatrneurol.2017.12.016. Epub 2018 Feb 14. Review.

PMID:
29909138
26.

Embryonal Tumor with Multilayered Rosettes Presenting with Intermittent Third Nerve Palsy.

Leal Ferman LA, Daigle P, Weil A, Ellezam B, Hamel P, Perreault S.

Can J Neurol Sci. 2018 Jul;45(4):483-484. doi: 10.1017/cjn.2018.23. Epub 2018 Jun 8. No abstract available.

PMID:
29880079
27.

Long-term Mortality After Acute Kidney Injury in the Pediatric ICU.

Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, Jouvet P, Lafrance JP, LeLorier J, Phan V, Palijan A, Pizzi M, Roy L, Zappitelli M.

Hosp Pediatr. 2018 May;8(5):260-268. doi: 10.1542/hpeds.2017-0215.

28.

Patients' Perception of Newly Initiated Oral Anticoagulant Treatment for Atrial Fibrillation: an Observational Study.

Larochelle J, Brais C, Blais L, Perreault S, Farand P, Letemplier G, Beauchesne MF.

J Gen Intern Med. 2018 Aug;33(8):1239-1241. doi: 10.1007/s11606-018-4457-z. No abstract available.

PMID:
29700791
29.

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM.

Blood Adv. 2018 Apr 24;2(8):923-932. doi: 10.1182/bloodadvances.2018016121.

30.

Healthcare Utilization after Acute Kidney Injury in the Pediatric Intensive Care Unit.

Hessey E, Morissette G, Lacroix J, Perreault S, Samuel S, Dorais M, Phan V, Jouvet P, Lafrance JP, LeLorier J, Palijan A, Pizzi M, Roy L, Zappitelli M.

Clin J Am Soc Nephrol. 2018 May 7;13(5):685-692. doi: 10.2215/CJN.09350817. Epub 2018 Apr 20.

31.

Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study.

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1754-1758. doi: 10.1016/j.bbmt.2018.03.025. Epub 2018 Apr 9.

PMID:
29649620
32.

Development of Quality Indicators to Assess Oral Anticoagulant Management in Community Pharmacies for Patients with Atrial Fibrillation.

Chartrand M, Guénette L, Brouillette D, Côté S, Huot R, Landry J, Martineau J, Perreault S, White-Guay B, Williamson D, Martin É, Gagnon MM, Lalonde L.

J Manag Care Spec Pharm. 2018 Apr;24(4):357-365. doi: 10.18553/jmcp.2018.24.4.357.

33.

Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Perreault S, Shahabi P, Côté R, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Mongrain I, Dorais M, Huynh T, Kouz S, Diaz A, Blostein M, de Denus S, Turgeon J, Ginsberg J, Lelorier J, Lalonde L, Busque L, Kassis J, Talajic M, Tardif JC, Dubé MP.

Clin Cardiol. 2018 May;41(5):576-585. doi: 10.1002/clc.22948. Epub 2018 May 15.

34.

Utility of fosfomycin as antibacterial prophylaxis in patients with hematologic malignancies.

Zapolskaya T, Perreault S, McManus D, Topal JE.

Support Care Cancer. 2018 Jun;26(6):1979-1983. doi: 10.1007/s00520-017-4040-x. Epub 2018 Jan 10.

PMID:
29322242
35.

Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.

Domon-Archambault V, Gagnon L, Benoît A, Perreault S.

J Child Neurol. 2018 Mar;33(3):225-232. doi: 10.1177/0883073817749367. Epub 2018 Jan 10.

PMID:
29318935
36.

A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.

Korol S, Mottet F, Perreault S, Baker WL, White M, de Denus S.

Medicine (Baltimore). 2017 Dec;96(48):e8719. doi: 10.1097/MD.0000000000008719. Review.

37.

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort.

Shahabi P, Lamothe F, Dumas S, Rouleau-Mailloux É, Feroz Zada Y, Provost S, Asselin G, Mongrain I, Valois D, Gaulin Marion MJ, Lemieux Perreault LP, Perreault S, Dubé MP.

Pharmacogenomics J. 2019 Apr;19(2):147-156. doi: 10.1038/s41397-017-0005-1. Epub 2018 Jan 3.

PMID:
29298995
38.

Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation.

Lavoie K, Turgeon MH, Brais C, Larochelle J, Blais L, Farand P, Letemplier G, Perreault S, Beauchesne MF.

J Atr Fibrillation. 2016 Dec 31;9(4):1478. doi: 10.4022/jafib.1478. eCollection 2016 Dec.

39.

Psychometric analysis of the TRANSIT quality indicators for cardiovascular disease prevention in primary care.

Khanji C, Bareil C, Hudon E, Goudreau J, Duhamel F, Lussier MT, Perreault S, Lalonde G, Turcotte A, Berbiche D, Martin É, Lévesque L, Gagnon MM, Lalonde L.

Int J Qual Health Care. 2017 Dec 1;29(8):999-1005. doi: 10.1093/intqhc/mzx145.

PMID:
29190350
40.

Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study.

Simard P, Presse N, Roy L, Dorais M, White-Guay B, Räkel A, Perreault S.

Ann Pharmacother. 2018 Apr;52(4):305-313. doi: 10.1177/1060028017743517. Epub 2017 Nov 16.

PMID:
29144162
41.

Comparison of Surgery and Radiation as Local Treatments in the Risk of Locoregional Complications in Men Subsequently Dying From Prostate Cancer.

Hu J, Aprikian AG, Cury FL, Vanhuyse M, Zakaria AS, Richard PO, Perreault S, Dragomir A.

Clin Genitourin Cancer. 2017 Sep 5. pii: S1558-7673(17)30266-5. doi: 10.1016/j.clgc.2017.08.011. [Epub ahead of print]

PMID:
28943330
42.

Increase in Psychoactive Drug Prescriptions in the Years Following Autism Spectrum Diagnosis: A Population-Based Cohort Study.

Croteau C, Mottron L, Presse N, Tarride JE, Dorais M, Perreault S.

J Popul Ther Clin Pharmacol. 2017 Aug 18;24(3):e19-e32. doi: 10.22374/1710-6222.24.3.2.

PMID:
28873291
43.

Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.

Robert-Boire V, Rosca L, Samson Y, Ospina LH, Perreault S.

Pediatr Neurol. 2017 Oct;75:55-60. doi: 10.1016/j.pediatrneurol.2017.06.019. Epub 2017 Jul 6.

PMID:
28847625
44.

Brainstem angiocentric gliomas with MYB-QKI rearrangements.

D'Aronco L, Rouleau C, Gayden T, Crevier L, Décarie JC, Perreault S, Jabado N, Bandopadhayay P, Ligon KL, Ellezam B.

Acta Neuropathol. 2017 Oct;134(4):667-669. doi: 10.1007/s00401-017-1763-1. Epub 2017 Aug 12. No abstract available.

45.

Combination liposomal amphotericin B, posaconazole and oral amphotericin B for treatment of gastrointestinal Mucorales in an immunocompromised patient.

Anderson A, McManus D, Perreault S, Lo YC, Seropian S, Topal JE.

Med Mycol Case Rep. 2017 May 24;17:11-13. doi: 10.1016/j.mmcr.2017.05.004. eCollection 2017 Sep.

46.

Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies.

Kuate Defo B, Mbanya JC, Tardif JC, Ekundayo O, Perreault S, Potvin L, Cote R, Kengne AP, Choukem SP, Assah F, Kingue S, Richard L, Pongou R, Frohlich K, Saji J, Fournier P, Sobngwi E, Ridde V, Dubé MP, De Denus S, Mbacham W, Lafrance JP, Nsagha DS, Mampuya W, Dzudie A, Cloutier L, Zarowsky C, Tanya A, Ndom P, Hatem M, Rey E, Roy L, Borgès Da Silva R, Dagenais C, Todem D, Weladji R, Mbanya D, Emami E, Njoumemi Z, Monnais L, Dubois CA.

JMIR Res Protoc. 2017 May 29;6(5):e102. doi: 10.2196/resprot.7807.

47.

Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study.

Perreault S, Nuevo J, Baumgartner S, Morlock R.

World J Nephrol. 2017 May 6;6(3):132-142. doi: 10.5527/wjn.v6.i3.132.

48.

Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.

Brais C, Larochelle J, Turgeon MH, Blais L, Farand P, Perreault S, Letemplier G, Beauchesne MF.

J Pharm Pharm Sci. 2017;20:8-14. doi: 10.18433/J30W4F.

49.

Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856.

Perreault S, Chandrasekhar J, Cui ZH, Evarts J, Hao J, Kaplan JA, Kashishian A, Keegan KS, Kenney T, Koditek D, Lad L, Lepist EI, McGrath ME, Patel L, Phillips B, Therrien J, Treiberg J, Yahiaoui A, Phillips G.

J Med Chem. 2017 Feb 23;60(4):1555-1567. doi: 10.1021/acs.jmedchem.6b01821. Epub 2017 Feb 7.

PMID:
28106991
50.

Relation between temporal perception and inhibitory control in the Go/No-Go task.

Brown SW, Perreault ST.

Acta Psychol (Amst). 2017 Feb;173:87-93. doi: 10.1016/j.actpsy.2016.12.004. Epub 2016 Dec 23.

PMID:
28024254

Supplemental Content

Loading ...
Support Center